Two different first problems
Providers who put these two on the same shortlist are usually solving one of two problems, and which one they are solving decides the answer before any feature list is opened.
CentralReach sells breadth: one system intended to carry an organization from intake through claim submission and remittance, with a decade of accumulated depth aimed at large, multi-site agencies. Noteable’s centre of gravity is documentation and clinical workflow — the note, the treatment plan, and what happens to them afterwards — for behavioral health providers whose pain is what clinicians spend their evenings doing rather than what the billing department spends its month-end on.
Both descriptions can be true of the same organization at different times, which is why this comparison so often reduces to sequencing: is the documentation burden costing you more this year than the revenue cycle is?
What to compare them on
Structure for your own evaluation. Cells are deliberately unfilled pending dated public sources — see the note above.
| MegAligna | Noteable | CentralReach | |
|---|---|---|---|
| Published pricing | Yes | No | No |
| Priced per active clinical seat, clients free | Yes | No | No |
| Direct electronic claim submission 3 | No | No | Yes |
- 3 The row that most often decides this comparison, and the row where we lose. Providers that submit their own claims electronically should not be evaluating us at all.
The questions worth putting to both, in your own numbers rather than at list price:
- What is the total at our actual headcount and caseload?
- How long does a clinician take to complete a routine note, measured rather than demonstrated?
- What happens to in-progress documentation when a device loses connectivity?
- What does a full export of our own records look like on the day we leave?
If documentation is the reason you are shopping, insist on timing a routine note — written by one of your own clinicians, on a test client — during the evaluation. Note-completion time is the one number that separates these products in daily use and the one that never appears on a feature grid.
Where MegAligna fits, and where it does not
What is genuinely different here: prices are published, billing is per active clinical seat with clients never charged for, and session capture survives a dropped connection rather than losing in-progress data — which is a documentation claim before it is a technical one, because the note a technician loses in a basement with no signal is the note they rewrite from memory that evening. See clinical notes for what that actually looks like.
What is genuinely missing: claims are not transmitted to payers. Finished charges and CMS-1500 field data go to your biller.
Three situations make staying put the right call, and they apply to either incumbent: you submit your own claims, you depend on a capability built over a decade that we have not built, or you are mid-audit.
Common questions
Which one is cheaper?
Is Noteable only for ABA?
Is CentralReach private-equity owned?
Can we run a new system alongside the old one?
Time a test note yourself
14 days, no card required. Use made-up patients while you evaluate — real patient information waits until a business associate agreement is in place.